Skip to main content
SLAS2024 Main banner
Sartorius Ad

  • Monday, Feb 5th
    10:00 AM – 12:00 PM EST
    Advanced Imaging and High Content Assays
    Room/Location:  205ABC
    Clarence Yapp, PhD – Harvard Medical School
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    10:00 AM – 10:30 AM EST
    Elucidating human intestinal regeneration using patient-derived organoids
    Room/Location:  205ABC
    Maurice Kahnwald (he/him/his) – Friedrich Miescher Institute for Biomedical Research
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    10:30 AM – 11:00 AM EST
    2D & 3D highly multiplexed imaging using cyclic immunofluorescence (CyCIF) for understanding disease mechanisms
    Room/Location:  205ABC
    Clarence Yapp, PhD – Harvard Medical School
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    11:00 AM – 11:30 AM EST
    Bioengineered immunocompetent human leukemia chip to preclinically screen CAR T cell immunotherapy
    Room/Location:  205ABC
    Chao Ma, PhD – New York University
    Assay Development and Screening (Room 205ABC)
    Sponsored By 
  • Monday, Feb 5th
    11:30 AM – 12:00 PM EST
    OrganoidChip: an all-in-one solution for culturing and blur-free imaging of intestinal organoids
    Room/Location:  205ABC
    Khashayar Moshksayan – University of Texas at Austin
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    3:00 PM – 5:00 PM EST
    Application of Functional Genomic Technologies in Drug Discovery
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    3:00 PM – 3:30 PM EST
    The Joint AstraZeneca - Cancer Research Horizons Functional Genomics Centre (FGC): A pioneering partnership driving oncology target discovery using pooled CRISPR screening
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    3:30 PM – 4:00 PM EST
    Pooled CRISPR screens for the identification of neurological disease modulators
    Room/Location:  205ABC
    Lara H. El Touny, PhD (she/her/hers) – National Center for Advancing Translational Sciences (NCATS)
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    4:00 PM – 4:30 PM EST
    Identification of high-quality tractable targets in primary immune cells: Combining chemogenomic and functional genomic screening technologies.
    Room/Location:  205ABC
    Tim Ashlin – GSK
    Assay Development and Screening (Room 205ABC)
  • Monday, Feb 5th
    4:30 PM – 5:00 PM EST
    Enabling discovery at the single patient resolution with digital microfluidics
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    10:00 AM – 12:00 PM EST
    Screening with Higher Throughput Multi-omic Assays: Enabling More Disease Relevance in Early Drug Discovery
    Room/Location:  205ABC
    Sarantis Chlamydas, Dr – Olink Proteomics
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    10:00 AM – 10:30 AM EST
    Next-generation proteomics in the era of multiomics and precision medicine
    Room/Location:  205ABC
    Sarantis Chlamydas, Dr – Olink Proteomics
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    10:30 AM – 11:00 AM EST
    The potential of cancer subtype prediction using large scale proteomics
    Room/Location:  205ABC
    Ben Busby, PhD – DNAnexus
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    11:00 AM – 11:30 AM EST
    High Dimensional Experimental Design (HDED) and novel cell-based assay approaches to accelerate drug discovery
    Room/Location:  205ABC
    Andreas Hock, PhD – AstraZeneca
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    11:30 AM – 12:00 PM EST
    High throughput, nanomole scale PROTACs discovery platform by direct screening of reaction mixtures
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    3:00 PM – 5:00 PM EST
    Decoding Complex Biology Through Translational Cellular Assays 
    Room/Location:  205ABC
    Jennifer Smith, PhD (she/her/hers) – Harvard Medical School
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    3:00 PM – 3:30 PM EST
    Integrated Phenotypic and Ion Channel-focused Assays for Drug Discovery in Pain
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    3:30 PM – 4:00 PM EST
    Application of High-Throughput Human Airway Microphysiological System for SARS-CoV-2 Infection Modeling and Therapeutic Screening
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    4:00 PM – 4:30 PM EST
    An automated and multiplexed liver fibrosis screening assay on a microfluidic liver model that replicates the cellular composition and organization of the hepatic lobule
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Tuesday, Feb 6th
    4:30 PM – 5:00 PM EST
    A New High-Throughput Screening Assay System Incorporating Drug Metabolic Capability for Evaluation of Compound Activity
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    9:30 AM – 11:30 AM EST
    Biochemical and Biophysical Assays
    Room/Location:  205ABC
    Ralph Mazitschek, PhD (he/him/his) – Massachusetts General Hospital/Harvard Medical School
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    9:30 AM – 10:00 AM EST
    CoraFluors: A User-friendly TR-FRET Assay Technology for PROTAC Profiling and Beyond.
    Room/Location:  205ABC
    Ralph Mazitschek, PhD (he/him/his) – Massachusetts General Hospital/Harvard Medical School
    Assay Development and Screening (Room 205ABC)Innovation Award
    Sponsored By 
  • Wednesday, Feb 7th
    10:00 AM – 10:30 AM EST
    Exploring targets in tropical diseases through the Novartis FAST Lab
    Room/Location:  205ABC
    Douglas S. Auld, PhD (he/him/his) – Novartis-CBT-HTB-2
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    10:30 AM – 11:00 AM EST
    Leveraging High Throughput Biochemical/Biophysical Tools to Discover and Characterize Novel Molecular Glues
    Room/Location:  205ABC
    Bradley DeMarco (he/him/his) – Monte Rosa Therapeutics
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    11:00 AM – 11:30 AM EST
    HTS-screening Technology Platform: Helicases Inhibitors
    Room/Location:  205ABC
    Restuan Lubis, M.Res (he/him/his) – Lead Discovery Center GmbH
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    12:30 PM – 2:30 PM EST
    Productive Strategies for Accessing and Assaying the Chemical Diversity from Nature
    Room/Location:  205ABC
    Barry O'Keefe, PhD – Frederick National Laboratory for Cancer Research, NCI
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    12:30 PM – 1:00 PM EST
    Hollow microparticle-based platform for the screening of millions of colonies producing natural products
    Room/Location:  205ABC
    Assay Development and Screening (Room 205ABC)Innovation Award
    Sponsored By 
  • Wednesday, Feb 7th
    1:00 PM – 1:30 PM EST
    Phenotypic Screening in Natural Products Discovery
    Room/Location:  205ABC
    John MacMillan, PhD – University of California, Santa Cruz
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    1:30 PM – 2:00 PM EST
    Accessing Natural Product Chemical Diversity for High Throughput Screening
    Room/Location:  205ABC
    Barry O'Keefe, PhD – Frederick National Laboratory for Cancer Research, NCI
    Assay Development and Screening (Room 205ABC)
  • Wednesday, Feb 7th
    2:00 PM – 2:30 PM EST
    Quantitative bioactivity signatures of dietary supplements and natural products
    Room/Location:  205ABC
    Adam Yasgar – NIH/NCATS
    Assay Development and Screening (Room 205ABC)